Press Releases
-
October 01, 2020
Omnicell Completes Acquisition of Pharmaceutical Strategy Group’s Leading 340B Software-Enabled Service Business
Omnicell, Inc. (NASDAQ: OMCL) announced it has completed the previously announced acquisition of Pharmaceutical Strategies Group’s (PSG) 340B Link business.
-
August 17, 2020
Peninsula Regional Medical Center Extends Partnership with Omnicell to Enhance Safety and Efficiency in Sterile Compounding
Maryland-based Peninsula Regional Medical Center has chosen Omnicell's industry-leading medication management platform to support their in-house sterile compounding operations.
-
August 12, 2020
Omnicell to Acquire Pharmaceutical Strategy Group’s Leading 340B Software-Enabled Service Business
Omnicell, Inc. (NASDAQ: OMCL) announced it has entered into a definitive agreement with Pharmaceutical Strategies Group (PSG) to acquire its 340B Link business.
-
July 28, 2020
Omnicell Reports Second Quarter 2020 Results
Omnicell, Inc. (NASDAQ: OMCL) announces results for its second quarter ended June 30, 2020.
-
July 20, 2020
Omnicell Streamlines Pharmacy Supply Chain Through Cloud-Based Predictive Intelligence Solution
Omnicell announced that it continues to deliver innovation to support the fully Autonomous Pharmacy through the launch of Omnicell One™, a predictive pharmacy intelligence solution that will be generally available in August 2020.
-
May 07, 2020
Omnicell Reports First Quarter 2020 Results
Omnicell, Inc. (NASDAQ: OMCL) announces results for its first quarter ended March 31, 2020.
-
February 10, 2020
Geisinger Optimizes Hospital Efficiency and Safety with Continued Investment in Omnicell XT Series Automated Dispensing Systems
Omnicell announced that it has partnered with Geisinger to help drive clinical and operational efficiency, increase medication safety and reduce costs—ultimately supporting enhanced patient care.
-
February 06, 2020
Omnicell Reports Fiscal Year and Fourth Quarter 2019 Results
Omnicell, Inc. (NASDAQ: OMCL) announces results for its fiscal year and fourth quarter ended December 31, 2019.
-
February 03, 2020
Omnicell Enhances Robotic IV Insourcing Offerings and Ramps up Investment in IV Automation Technology
Omnicell announced significant clinical enhancements and expansion of the Company’s unique IV compounding service, which combines advanced technology, clinical expertise, operational support, and workflow/analytics to address challenges in sterile compounding.
-
January 28, 2020
Multiple Health Systems Help Optimize Efficiency and Patient Safety by Adopting Omnicell’s Point of Care Automated Workflow Technology
Leading-edge health systems across North America are adopting the Omnicell's point-of-care automated workflow technology.
-
January 26, 2020
Omnicell Showcases Latest Advancements to Medication Management Portfolio at Arab Health Exhibition and Congress
Omnicell will be showcasing the latest advancements to its medication management portfolio at the Arab Health Exhibition and Congress from 27-30 January in Dubai.
-
January 21, 2020
Allegheny General Hospital Partners with Omnicell to Automate Sterile Compounding
Allegheny General Hospital, Pittsburgh, Pa., part of Allegheny Health Network (AHN), has selected Omnicell’s Central Pharmacy IV Compounding Service, a comprehensive, turnkey approach for insourcing sterile compounding operations.
-
December 09, 2019
Omnicell and Kit Check Partner to Offer Cloud-based Solution for Tracking of Controlled Substances
Medication intelligence software solution supports critical need for hospitals and health systems to identify drug diversion to combat national opioid crisis.
-
December 09, 2019
Omnicell and Huron to Provide Outcome-Based Professional Services
Comprehensive approach to project implementation and change management will lead to faster technology adoption and improved ROI
-
December 05, 2019
Omnicell to Unveil Latest Advancements to Its Medication Management Solution Portfolio in Automation, Intelligence, and Services at 2019 ASHP Midyear Meeting
New innovations and service capabilities are latest milestone in autonomous pharmacy roadmap designed to create a zero-error, fully automated medication management infrastructure.
-
October 24, 2019
Omnicell Achieves Record Revenue in the Third Quarter 2019
Omnicell, Inc. (NASDAQ: OMCL) announces results for its third quarter ended September 30, 2019.
Previous